Another limitation of this analysis is that recent data suggest that Fluciclovine PET imaging may be inferior to detecting low volume recurrent disease compared to PSMA imaging in the BCR PCa setting,21 however given that both imaging modalities are routinely ordered at time of recurrence this analysis combined all molecular imaging available at the study site. Here, FOLH1 is linked to posterior cortical atrophy.